Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Vishnu Chemicals Ltd (VISHNU)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 516072 NSE: VISHNU Chemicals | Small Cap | Vishnu Chemicals Share Price
₹691 -8.10 (-1.16%)
As on 28-Sep'26 13:27
Vishnu Chemicals Ltd (VISHNU)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 516072 NSE: VISHNU Chemicals | Small Cap | Vishnu Chemicals Share Price
₹691 -8.10 (-1.16%)
As on 28-Sep'26 13:27
Key Metrics
Valuation Multiples
Market Cap
₹4,706 Cr.
Current Price
₹691
52-Week Low / High
₹444 / 743
TTM EPS
₹22.2
TTM Sales
₹1,689 Cr.
Book Value per Share
₹164.7
P/E Ratio
31.44
Higher than its 5-year historical median
Industry PE
48
Price to Book (P/B)
4.24
Lower than its 5-year historical median
Price to Sales (P/S)
2.79
Higher than its 5-year historical median
EV/EBITDA
17.52
Higher than its 5-year historical median
Dividend Yield
0.04%
Profitability Efficiency
Return on Equity (ROE)
14.26%
Outperforms industry median
Return on Capital Employed (ROCE)
16.38%
Outperforms industry median
Return on Assets (ROA)
7.65%
Operating Profit Margin
15.7%
Net Profit Margin
8.84%
Gross Profit Margin
14.7%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
11.36%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
10.39%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
12.34%
Asset Quality
Promoter Holding
69.21%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹1,095 Cr.
Equity
₹13.5 Cr.
Face Value
₹2
All Time Low / High
₹0.10 / 743.35
Check Before You Invest
Quality
Very GoodValuation
OvervaluedCheck Valuation charts
Price Trend
Strong
Is Vishnu Chemicals Ltd a good quality company?
Vishnu Chemicals Ltd is a good quality company, based on a consistently good multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Vishnu Chemicals Ltd performance compare with that of its Peers?
Revenue growth of Vishnu Chemicals Ltd vs industry peers?
Vishnu Chemicals Ltd revenue CAGR is 18.85%, compared to the industry median CAGR of 0%, indicating faster growth and gaining its market share.
Promoter shareholding and pledge status of Vishnu Chemicals Ltd?
Promoters hold 69.21% of the Vishnu Chemicals Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Vishnu Chemicals Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 27.9% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Vishnu Chemicals Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good
Value Creation ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 14.2% | 14.5% | 15.1% | 13% | 10.4% | 22.7% | 35.9% | 21.1% | 14.7% | 14.2% | - |
| Value Creation Index ⓘ | 0.0 | 0.0 | 0.1 | -0.1 | -0.3 | 0.6 | 1.6 | 0.5 | 0.1 | 0.0 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 439 | 562 | 668 | 571 | 573 | 907 | 1,222 | 1,011 | 1,098 | 1,222 | 1,252 |
| Sales YoY Gr. | - | 28.1% | 18.8% | -14.4% | 0.3% | 58.2% | 34.8% | -17.3% | 8.6% | 11.4% | - |
| Adj EPS ⓘ | 0.4 | 0.9 | 2.5 | 2 | 3.9 | 10.6 | 20.2 | 13.7 | 11.3 | 11.5 | 15.3 |
| YoY Gr. | - | 145.7% | 193% | -21.4% | 98% | 170.7% | 90% | -32.1% | -17.6% | 2.4% | - |
| BVPS (₹) ⓘ | 15.1 | 16.7 | 19.8 | 21.3 | 25.4 | 36.2 | 57.9 | 96.2 | 116.7 | 129 | 133.8 |
| Adj Net Profit ⓘ | 2.1 | 5.1 | 15 | 11.8 | 23.4 | 63.4 | 120 | 89.6 | 75.9 | 77.7 | 103 |
| Cash Flow from Ops. ⓘ | 71.8 | 78.4 | 93.1 | 34.7 | 48.8 | 88 | 97.1 | 79.7 | 26.5 | 106 | - |
| Debt/CF from Ops. ⓘ | 4.2 | 4.6 | 3.6 | 9.3 | 6.8 | 3.6 | 2.7 | 2.7 | 7.4 | 2.3 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 12.1% | 16.4% | 0% | 11.4% | ||||
| Adj EPS ⓘ | 47.5% | 24.1% | -17% | 2.4% | ||||
| BVPSⓘ | 26.9% | 38.5% | 30.6% | 10.6% | ||||
| Share Price | 28% | 36.5% | 28.2% | 46.2% | ||||
Key Financial Parameters ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 1.7 | 5.4 | 13.8 | 9.6 | 16.8 | 34.5 | 42.8 | 18.4 | 10.7 | 9.4 | 11.6 |
| Op. Profit Mgn % ⓘ | 13.6 | 12.4 | 13 | 11.7 | 10.9 | 14.1 | 17.1 | 15.7 | 13.2 | 11.6 | 12.1 |
| Net Profit Mgn % ⓘ | 0.5 | 0.9 | 2.3 | 2.1 | 4.1 | 7 | 9.9 | 8.9 | 6.9 | 6.4 | 8.2 |
| Debt to Equity ⓘ | 3.3 | 3.6 | 2.8 | 2.5 | 2.2 | 1.5 | 0.8 | 0.3 | 0.3 | 0.3 | - |
| Working Cap Days ⓘ | 248 | 217 | 196 | 212 | 203 | 139 | 119 | 168 | 192 | 209 | 104 |
| Cash Conv. Cycle ⓘ | 80 | 72 | 73 | 88 | 82 | 57 | 44 | 69 | 91 | 87 | 44 |
Valuation of Vishnu Chemicals - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 3.84 | 3.84 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 507 | 643 | 769 | 674 | 679 | 1,069 | 1,391 | 1,213 | 1,447 | 1,610 |
| Operating Expenses ⓘ + | 441 | 562 | 667 | 591 | 600 | 911 | 1,160 | 1,010 | 1,217 | 1,356 |
| Operating Profit ⓘ | 66 | 81 | 102 | 82 | 79 | 158 | 231 | 202 | 229 | 253 |
| Operating Profit Margin (%) | 13.1% | 12.6% | 13.3% | 12.2% | 11.6% | 14.7% | 16.6% | 16.7% | 15.9% | 15.7% |
| Other Income ⓘ + | 7 | 8 | 3 | 7 | 3 | 6 | 15 | 12 | 15 | 23 |
| Interest ⓘ | 44 | 49 | 47 | 39 | 27 | 28 | 35 | 37 | 38 | 39 |
| Depreciation ⓘ | 16 | 19 | 21 | 20 | 20 | 23 | 26 | 34 | 38 | 41 |
| Profit Before Tax ⓘ | 14 | 22 | 37 | 30 | 34 | 112 | 185 | 144 | 168 | 195 |
| Tax ⓘ | 7 | 8 | 13 | 8 | -0 | 31 | 49 | 43 | 42 | 53 |
| Profit After Tax | 7 | 14 | 24 | 22 | 34 | 81 | 137 | 101 | 127 | 142 |
| PAT Margin (%) | 1.3% | 2.2% | 3.2% | 3.3% | 5.1% | 7.6% | 9.8% | 8.3% | 8.8% | 8.8% |
| Adjusted EPS (₹) | 1.1 | 2.4 | 4.1 | 3.7 | 5.8 | 13.6 | 22.9 | 15.4 | 18.8 | 21.1 |
| Dividend Payout Ratio (%) | 0% | 8.30% | 4.90% | 5.40% | 3.50% | 2.90% | 1.80% | 1.90% | 1.60% | 1.40% |
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 97 | 111 | 142 | 160 | 196 | 277 | 414 | 701 | 927 | 1,069 | |
| Debt + | 301 | 359 | 330 | 315 | 306 | 330 | 335 | 292 | 322 | 486 | |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | |
| Trade Payables | 127 | 178 | 139 | 138 | 137 | 171 | 177 | 227 | 287 | 365 | |
| Others Liabilities ⓘ | 169 | 133 | 145 | 122 | 133 | 137 | 124 | 105 | 99 | 162 | |
| Total Liabilities ⓘ | 694 | 782 | 757 | 735 | 773 | 915 | 1,051 | 1,325 | 1,634 | 2,088 | |
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 290 | 349 | 350 | 338 | 387 | 463 | 465 | 635 | 702 | 836 | |
| CWIP ⓘ | 62 | 17 | 19 | 36 | 24 | 5 | 98 | 16 | 69 | 159 | |
| Investments ⓘ | 1 | 1 | 1 | 1 | 1 | 3 | 2 | 2 | 0 | 1 | |
| Inventories | 170 | 182 | 189 | 208 | 191 | 168 | 207 | 317 | 403 | 513 | |
| Trade Receivables | 96 | 144 | 134 | 91 | 116 | 191 | 181 | 230 | 294 | 310 | |
| Cash Equivalents | 13 | 18 | 14 | 15 | 11 | 15 | 21 | 60 | 82 | 100 | |
| Others Assets ⓘ | 62 | 70 | 49 | 45 | 43 | 70 | 77 | 66 | 84 | 169 | |
| Total Assets ⓘ | 694 | 782 | 757 | 735 | 773 | 915 | 1,051 | 1,325 | 1,634 | 2,088 | |
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 73 | 89 | 100 | 49 | 67 | 94 | 134 | 67 | 90 | 127 |
| Cash Flow From Investing Activity ⓘ + | -98 | -33 | -23 | -22 | -52 | -86 | -118 | -154 | -100 | -267 |
| Cash Flow From Financing Activity ⓘ + | 25 | -56 | -78 | -24 | -19 | -9 | -16 | 88 | 10 | 146 |
| Net Cash Flow ⓘ | 0 | 0 | -1 | 4 | -4 | 0 | 0 | 2 | 0 | 5 |
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 6.08 | 13.85 | 19.21 | 14.7 | 19.37 | 34.41 | 39.51 | 18.13 | 15.56 | 14.26 |
| ROCE (%) | 14.4 | 15.5 | 17.17 | 14.24 | 12.05 | 23.95 | 30.71 | 20.03 | 18.08 | 16.38 |
| Asset Turnover Ratio | 0.83 | 0.88 | 1 | 0.9 | 0.9 | 1.27 | 1.42 | 1.02 | 0.98 | 0.86 |
| PAT to CFO Conversion(x) | 10.43 | 6.36 | 4.17 | 2.23 | 1.97 | 1.16 | 0.98 | 0.66 | 0.71 | 0.89 |
| Working Capital Days | ||||||||||
| Receivable Days | 70.60 | 67.10 | 66 | 61 | 55.60 | 52.30 | 48.80 | 61.80 | 66.10 | 68.50 |
| Inventory Days | 114.80 | 98.70 | 88.20 | 107.60 | 107.10 | 61.20 | 49.20 | 78.90 | 90.80 | 103.80 |
| Payable Days | 201.20 | 181.80 | 168 | 167.70 | 174.30 | 131.10 | 118.30 | 166.70 | 153.80 | 172 |
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Vishnu Chemicals Ltd FAQs
The current trading price of Vishnu Chemicals on 28-Sep-2026 13:27 is ₹691.0.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 27-Sep-2026 the market cap of Vishnu Chemicals stood at ₹4,706 Cr
The latest P/E ratio of Vishnu Chemicals as of 27-Sep-2026 is 45.79.
The latest P/B ratio of Vishnu Chemicals as of 27-Sep-2026 is 5.23.
The 52-week high of Vishnu Chemicals is ₹743.4 and the 52-week low is ₹444.2.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Vishnu Chemicals is ₹1,252 ( Cr.) .
Past 10 year's financial track record analysis by Moneyworks4me indicates that Vishnu Chemicals Ltd is a good quality company.
The key valuation ratios of Vishnu Chemicals Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Vishnu Chemicals Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing
About Vishnu Chemicals Ltd
Ch.Krishna Murthy founded Vishnu Chemicals in the year 1990 near Hyderabad in Andhra Pradesh. In a span of 17 years Vishnu Chemicals pioneered manufacturing chrome chemicals like sodium dichromate, potassium dichromate, basic chromium sulphate and yellow sodium sulphate at its plants in Medak District in Andhra Pradesh and Bhilai in Chattisgarh.
It has expanded its product line to a point where it can supply over ten high quality compounds that are used in various industries which are include chromic acid, white sodium sulphate, saccharin and sodium saccharin.
The company also a world class manufacturer of animal feed ingredients like menadione sodium bisulfite, menadione nicotinamide bisulfite, menadione dimethylpyrimidinol bisulfite and supplying to various global destinations. Its growth and success is attributed to high standards of quality and diligence in handling customers requirements.
The company has established a world class state-of-the-art research laboratory with most modern equipment to handle gram level to scale-up operations in single site. The R&D Lab is also supported by quality control laboratory which has various sophisticated equipment like HPLCs, DSC and 300 MHz NMR among other sensitive equipments. Talented personnel handles the R&D and quality control operations. This facility is already catering to various clients for customs research and synthesis, technology transfer, scale-up and analytical services.
Product range of the company includes:
- Sodium Dichromate Dihydrate
- Basic Chromium Sulphate
- Chromic Acid
- Sodium Sulphate
- Potassium Dichromate
- Sodium Saccharin
- Menadione (Vitamin K3)
- Menadione Nicotinamide Bisulfite (MNB 44%) (Vitamin K3)
- Menadione Dimethylpyrimidinol Bisulfite (MPB 44%) (Vitamin K3)
Achievements/ recognition
- An ISO 9001 certification by BVQI
You have 49 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
